EphA2 is frequently detected at low levels in various normal epithelial cells, and its overexpression has been investigated in solid tumours, including glioma,6 non‐small cell lung cancer,7 gastric cancer,8 renal cell cancer,9 colorectal cancer and endometrial cancer.10 Here, EPHA2 is linked to gastric cancer.